Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

3,654 public trials 851 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

Study of Pralatrexate to Treat Participants With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma

NCT00998946

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • Tower Cancer Research Foundation Beverly Hills, California, United States
  • Kootenai Cancer Center Post Falls, Idaho, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • Owsley Brown Frazier Cancer Center Louisville, Kentucky, United States
View Trial Details
Completed

A Phase III Randomized Trial of Low-Dose Versus Standard-Dose mBACOD Chemotherapy With rGM-CSF for Treatment of AIDS-Associated Non-Hodgkin's Lymphoma

NCT00000658

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +21 more
Locations
  • USC CRS Los Angeles, California, United States
  • UCLA CARE Center CRS Los Angeles, California, United States
  • Ucsf Aids Crs San Francisco, California, United States
  • University of Colorado Hospital CRS Aurora, Colorado, United States
View all 22 locations
View Trial Details
Completed

Rituxan/BEAM vs Bexxar/BEAM in Autologous Hematopoietic Stem Cell Transplant for Non-Hodgkin's Lymphoma (BMTCTN0401)

NCT00329030

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Yale University School of Medicine New Haven, Connecticut, United States
  • University of Florida College of Medicine (Shands) Gainesville, Florida, United States
  • University of Miami Miami, Florida, United States
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
View all 36 locations
View Trial Details
Completed

Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma

NCT00865969

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Wilshire Oncology Medical Group, Inc La Verne, California, United States
  • Comprehensive Cancer Center Palm Springs, California, United States
  • Yale Cancer Center-Section of Medical Oncology New Haven, Connecticut, United States
View all 117 locations
View Trial Details
Completed

Brentuximab Vedotin and Gemcitabine Hydrochloride in Treating Younger Patients With Relapsed or Refractory Hodgkin Lymphoma

NCT01780662

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +9 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Kaiser Permanente Downey Medical Center Downey, California, United States
  • Loma Linda University Medical Center Loma Linda, California, United States
View all 116 locations
View Trial Details
Completed

Phase II Study of Filgrastim (G-CSF) Plus ABVD in the Treatment of HIV-Associated Hodgkin's Disease

NCT00000626

Conditions
AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +23 more
Locations
  • Alabama Therapeutics CRS Birmingham, Alabama, United States
  • USC CRS Los Angeles, California, United States
  • Northwestern University CRS Chicago, Illinois, United States
  • Indiana Univ. School of Medicine, Infectious Disease Research Clinic Indianapolis, Indiana, United States
View Trial Details

Related conditions